Earnings History Data for Athenex, Inc. (ATNX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Athenex, Inc.

Athenex, Inc. is a clinical stage biopharmaceutical company. It engaged in the discovery and development of drugs for the treatment of cancer. The company's platform including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. It operates primarily in Buffalo and Clarence, New York, Cranford, New Jersey, Houston, Texas, Chicago, Illinois, Hong Kong and Taipei Taiwan. Athenex, Inc. is based in Buffalo, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
20-03-2023	PM		ATNX	Athenex	15.00	-3.38	-1.00	0.00	Athenex GAAP EPS of -$4.28, revenue of $25.06M [3/20/2023 8:55 AM]	1.30	-0.46 (-26.14%)	1.65	-0.11 (-6.25%)	1.30 - 24.00	405,796	90,000	8,309
Athenex GAAP EPS of -$4.28, revenue of $25.06M [3/20/2023 8:55 AM]
03-11-2022	PM	7:00 AM ET (Nov 3)	ATNX	Athenex, Inc.	31.19	-0.14	-0.16	-0.33	Athenex reports Q3 earnings beat; reaffirms FY22 revenue guidance [11/3/2022 7:29 AM]	0.1967	0.0 (-1.01%)	0.21	0.01 (4.58%)	0.16 - 2.89	1,815,985	1,200,000	51,971
Athenex Q3 2022 Earnings Preview [11/2/2022 12:31 PM] Athenex reports Q3 earnings beat; reaffirms FY22 revenue guidance [11/3/2022 7:29 AM] Athenex receives positive Nasdaq listing determination [11/3/2022 7:36 AM]
28-07-2022	PM		ATNX	Athenex, Inc.	71.77	-0.23	-0.13	-0.33		0.5293	-0.01 (-1.45%)	0.56	0.03 (4.99%)	0.41 - 3.91	527,826	380,000	1,277
Athenex Q2 2022 Earnings Preview [7/27/2022 12:31 PM] Athenex GAAP EPS, revenue misses estimates [7/28/2022 7:42 AM] Athenex Provides Second Quarter 2022 Financial Results and Business Update [Jul-28-22 07:00AM]
10-05-2022	PM	(May 10)	ATNX	Athenex, Inc.	54.20	-0.24	-0.16	-0.27	Athenex GAAP EPS of -$0.16 beats by $0.03, revenue of $29.7M beats by $4.28M [5/10/2022 7:20 AM]	0.50	0.03 (7.23%)	0.48	0.01 (2.94%)	0.43 - 5.27	478,206	861,795	6,031
Athenex GAAP EPS of -$0.16 beats by $0.03, revenue of $29.7M beats by $4.28M [5/10/2022 7:20 AM] Athenex Provides First Quarter 2022 Financial Results and Business Update [May-10-22 07:00AM] Athenex (ATNX) Reports Q1 Loss, Tops Revenue Estimates [May-10-22 09:55AM]
16-03-2022	AH	After the close (Mar 16)	ATNX	Athenex, Inc.	92.16	-0.29	-0.04	-0.53	Athenex GAAP EPS of -$0.95 misses by $0.62, revenue of $24.94M misses by $5.88M [3/16/2022 5:07 PM]	0.9578	0.0 (-0.23%)	0.90	-0.06 (-6.25%)	0.73 - 5.75	866,588	852,476	2,701
Athenex implements cost saving measures as liquidity dries up [3/16/2022 4:51 PM] Athenex GAAP EPS of -$0.95 misses by $0.62, revenue of $24.94M misses by $5.88M [3/16/2022 5:07 PM] Athenex GAAP EPS of -$0.95 misses by $0.62, revenue of $24.94M misses by $5.88M [3/16/2022 5:14 PM] Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-16-22 04:10PM] Athenex reducing workforce, shifting research focus in effort to boost profitability [Mar-17-22 11:31AM]
05-08-2021	PM		ATNX	Athenex, Inc.	415.37	-0.33	-0.41	-0.41	Athenex EPS beats by $0.08, misses on revenue [8/5/2021 7:24 AM]	3.82	0.11 (2.96%)	3.42	-0.29 (-7.82%)	3.33 - 15.24	1,374,508	970,000	154,947
Athenex EPS beats by $0.08, misses on revenue [8/5/2021 7:24 AM] Is Athenex, Inc.'s (NASDAQ:ATNX) Shareholder Ownership Skewed Towards Insiders? [Aug-04-21 02:22AM] Athenex Provides Second Quarter 2021 Corporate and Financial Update [Aug-05-21 07:00AM] Athenex (ATNX) Reports Q2 Loss, Misses Revenue Estimates [Aug-05-21 08:45AM]
06-05-2021	PM	7:05 AM ET (May 6)	ATNX	Athenex, Inc.	346.72	-0.27	-0.37	-0.24	Athenex EPS beats by $0.13, beats on revenue [5/6/2021 7:14 AM]	4.28	-0.27 (-5.93%)	4.22	-0.06 (-1.40%)	3.66 - 15.24	11,411,635	23,160,000	23,233
Athenex EPS beats by $0.13, beats on revenue [5/6/2021 7:14 AM] Why Athenex Stock Skyrocketed Today [May-05-21 05:12PM] 5 Top Stock Gainers for Wednesday: Under Armour, Match, Athenex [May-05-21 08:48AM] Athenex Snaps Up Kuur Therapeutics For $185M; Street Sees 133.7% Upside [May-05-21 08:13AM] Athenex Shares Gain After Acquiring Kuur Therapeutics For $70M Cash, $115M Milestone Payments [May-05-21 07:00AM] Athenex Jumps on Plan to Buy Cancer-Therapy Developer Kuur [May-05-21 04:51AM] Athenex Provides First Quarter 2021 Corporate and Financial Update [May-06-21 07:00AM] Athenex (ATNX) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 09:35AM] Athenex, Inc. to Host Earnings Call [May-06-21 06:15AM]
01-03-2021	PM	7:00 AM ET (Mar 1)	ATNX	Athenex, Inc.	1,110	-0.53	-0.42	-0.28	Athenex EPS misses by $0.09, beats on revenue [3/1/2021 7:11 AM]	5.44	-6.66 (-55.04%)	5.60	-6.50 (-53.72%)	5.24 - 15.24	42,358,311	1,596,381	4,081,383
Athenex EPS misses by $0.09, beats on revenue [3/1/2021 7:11 AM] Athenex shares slide after Q4 results, FDA setback [3/1/2021 7:51 AM] Athenex (ATNX) shares down big on FDA rejection of oral paclitaxel application in breast cancer [3/1/2021 7:30 AM] SHAREHOLDER ALERT: Labaton Sucharow Investigates Claims On Behalf of Investors of Athenex, Inc. (NASDAQ: ATNX) [Mar-01-21 11:39AM] SHAREHOLDER ALERT: Athenex, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm [Mar-01-21 11:38AM] Athenex: Q4 Earnings Insights [Mar-01-21 07:39AM] Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer [Mar-01-21 07:00AM] Athenex, Inc. to Host Earnings Call [Mar-01-21 06:30AM] Athenex's Earnings Outlook [Feb-26-21 10:17AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	ATNX	Athenex, Inc.	1,120	-0.44	-0.46	-0.45	Athenex EPS in-line, beats on revenue [11/5/2020 7:12 AM]	12.33	0.17 (1.40%)	12.33	0.0 (0.00%)	5.63 - 18.35	760,100	412,888	6,512

06-08-2020	PM	7:00 AM ET (Aug 6)	ATNX	Athenex, Inc.	915.02	-0.41	-0.31	-0.44	Athenex EPS in-line, beats on revenue [8/6/2020 7:07 AM]	11.23	-0.17 (-1.49%)	11.40	0.0 (0.00%)	5.63 - 19.00	489,368	430,950	10,393